Stocks · Health care · Pharmaceutical Preparations

Dianthus Therapeutics, Inc.

DNTH Clue Score33
United States Fiscal year ends December CIK 0001690585 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Adam M Veness
13 Aug 2026
SVP, General Counsel and Sec.
Exercised, kept
15,000
$18.17
$272.55K
Marino Garcia
16 Mar 2026
CEO and President
Exercised, kept
5,592
$17.88
$99.98K
Marino Garcia
16 Mar 2026
CEO and President
Exercised, kept
59,700
$6.70
$399.99K

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 66
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 978,851
History held since 27 Jun 2018